ASCOLets hope we don' t hear any of the scientists state "pelarep shows promise and deserves further evaluation". This would be a death nil for the investment public. We need positive results and little doubt from this commnity about going forward to a registration trial. If there is any hope of a partnrship or buyout this will be the minimum expectation. It's now or never IMO.